Novel Soluable Gamma-Secretase Modulators

Funding year(s): 
2010
Funding to date: 
$250,000

Building on in vitro characterization of a novel series of soluable gamma-secretase modulators (SGSMs) funded by Cure Alzheimer’s Fund, the current project is a thorough pharmacological or in vivo examination of these molecules to identify the best or “lead” drug candidate.

Roadmap: